Pharma companies are required to continuously optimise their sales force resources or MR - medical reps and effectiveness, as they tighten their focus on profitability, as well as revenue growth, because as companies invest heavily in the development and field marketing of new therapies, they are also increasingly focusing on Return on Investment (ROI). In a dynamic market like this, where monitoring field activities is vital and new competitive threats emerge rapidly, there are bound to be massive changes overnight. Hence, there arrives a need to implement a pharma MR reporting software which is repetitive and a constant learning model that will enable pharma companies to identify different market shifts and build response plans in real time before their competitors can gain significant market share.

Not Given